SCHEMBL8007567

SCHEMBL8007567

OCc1ccc(COc2nn(Cc3ccccc3)c3ccccc23)o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 5/20 0.68
CNR1 P21554 4/20 0.68
ACHE P22303 4/20 0.68
PDE5A O76074 10/20 0.62
CYP1A2 P05177 3/20 0.62
CYP2D6 P10635 3/20 0.62
KDM4E B2RXH2 2/20 0.62
CYP3A4 P08684 2/20 0.62
NPC1 O15118 1/20 0.62
GMNN O75496 1/20 0.62
ALDH1A1 P00352 1/20 0.62
LMNA P02545 1/20 0.62
TP53 P04637 1/20 0.62
MAPT P10636 1/20 0.62
CYP2C9 P11712 1/20 0.62
HPGD P15428 1/20 0.62
ALOX15 P16050 1/20 0.62
NFKB1 P19838 1/20 0.62
MAPK1 P28482 1/20 0.62
CYP2C19 P33261 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6767172 0.91 CNR2 (0.68) CNR2CNR1ACHEPDE5ACYP1A2
SCHEMBL6764379 0.83 PDE5A (0.62) CNR2CNR1ACHEPDE5ACYP1A2
SCHEMBL3076501 0.79 PDE5A (0.66) CNR2CNR1ACHEPDE5ACYP1A2
SCHEMBL6764408 0.77 CNR2 (0.65) CNR2CNR1ACHEPDE5ACYP1A2
SCHEMBL187837 0.77 PDE5A (1.00) CNR2CNR1ACHEPDE5ACYP1A2
SCHEMBL29352550 0.77 PDE5A (1.00) CNR2CNR1ACHEPDE5ACYP1A2
SCHEMBL12092607 0.75 CNR2 (0.76) CNR2CNR1ACHEPDE5ACYP1A2
Bendazac SCHEMBL25979 0.75 CNR2 (0.70) CNR2CNR1ACHEPDE5ACYP1A2
SCHEMBL16772288 0.75 CYP1A2 (0.70) CNR2CNR1ACHEPDE5ACYP1A2
Bendazac SCHEMBL30299455 0.75 CNR2 (0.70) CNR2CNR1ACHEPDE5ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000027394-A1 ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE UNIVERSITY COLLEGE LONDON (GB) 2000-05-18 WO disclosed